13.87  1.3 (10.34%)		12-01 16:00
Open: 12.69 High: 13.915 Volume: 30,564		Pre. Close: 12.57 Low: 12.6061 Market Cap: 296(M)

Short term
Mid term
Targets	6-month :	17.28	1-year :	20.19
Resists	First :	14.8	Second :	17.28
Pivot price	13.19
Supports	First :	11.64	Second :	9.69
MAs	MA(5) :	12.98	MA(20) :	12.82
	MA(100) :	16.56	MA(250) :	16.22
MACD	MACD :	-0.4	Signal :	-0.6
%K %D	K(14,3) :	50.5	D(3) :	49.4
RSI	RSI(14): 52.3
52-week	High :	38.84	Low :	6.59

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CBUS ] has closed below upper band by 26.6%. Bollinger Bands are 58.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	13.67 - 13.75	13.75 - 13.81
Low:	12.38 - 12.48	12.48 - 12.55
Close:	12.44 - 12.59	12.59 - 12.69

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Fri, 01 Dec 2023
Cibus (CBUS) Announces European Union Notifies Trading ... - StreetInsider.com

Thu, 30 Nov 2023
2023-11-30 | NDAQ:CBUS | Press Release | Cibus Inc - Stockhouse Publishing

Fri, 24 Nov 2023
Both retail investors who control a good portion of Cibus, Inc ... - Yahoo Finance

Thu, 09 Nov 2023
Cibus: Q3 Earnings Snapshot - Beaumont Enterprise

Mon, 06 Nov 2023
European Parliament Releases Draft Report on the Proposal for the ... - Yahoo Finance

Thu, 02 Nov 2023
Cibus to Report Third Quarter 2023 Financial Results on November ... - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	4 (M)
Shares Float	0 (M)
Held by Insiders	1.67e+007 (%)
Held by Institutions	1.424e+007 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	157000
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-9.28
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	683.5 %
Return on Equity (ttm)	-3.5 %
Qtrly Rev. Growth	756000 %
Gross Profit (p.s.)	0
Sales Per Share	-0.01
EBITDA (p.s.)	0
Qtrly Earnings Growth	-1.943e+007 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	-1.5
Price to Sales	-2.44571e+006
Price to Cash Flow	0

Dividend	162510
Forward Dividend	109890
Dividend Yield	1171670%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.